Stevens M - Search Results

1

Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivatives.

Stevens M, Pannecouque C, De Clercq E, Balzarini J. Stevens M, et al. Antimicrob Agents Chemother. 2003 Sep;47(9):2951-7. doi: 10.1128/AAC.47.9.2951-2957.2003. Antimicrob Agents Chemother. 2003. PMID: 12937000 Free PMC article.

2

Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV action.

Stevens M, Pannecouque C, De Clercq E, Balzarini J. Stevens M, et al. Antimicrob Agents Chemother. 2003 Oct;47(10):3109-16. doi: 10.1128/AAC.47.10.3109-3116.2003. Antimicrob Agents Chemother. 2003. PMID: 14506017 Free PMC article.

3

The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.

Auwerx J, Stevens M, Van Rompay AR, Bird LE, Ren J, De Clercq E, Oberg B, Stammers DK, Karlsson A, Balzarini J. Auwerx J, et al. Among authors: stevens m. J Virol. 2004 Jul;78(14):7427-37. doi: 10.1128/JVI.78.14.7427-7437.2004. J Virol. 2004. PMID: 15220416 Free PMC article.

4

Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral action.

Balzarini J, Stevens M, De Clercq E, Schols D, Pannecouque C. Balzarini J, et al. Among authors: stevens m. J Antimicrob Chemother. 2005 Feb;55(2):135-8. doi: 10.1093/jac/dkh530. Epub 2005 Jan 13. J Antimicrob Chemother. 2005. PMID: 15650002 Review.

5

Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.

Stevens M, Balzarini J, Tabarrini O, Andrei G, Snoeck R, Cecchetti V, Fravolini A, De Clercq E, Pannecouque C. Stevens M, et al. J Antimicrob Chemother. 2005 Nov;56(5):847-55. doi: 10.1093/jac/dki328. Epub 2005 Sep 8. J Antimicrob Chemother. 2005. PMID: 16150861

6

Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture.

Balzarini J, Keyaerts E, Vijgen L, Vandermeer F, Stevens M, De Clercq E, Egberink H, Van Ranst M. Balzarini J, et al. Among authors: stevens m. J Antimicrob Chemother. 2006 Mar;57(3):472-81. doi: 10.1093/jac/dki481. Epub 2005 Dec 30. J Antimicrob Chemother. 2006. PMID: 16387746 Free PMC article.

7

Pyridine N-oxide derivatives inhibit viral transactivation by interfering with NF-kappaB binding.

Stevens M, Pannecouque C, De Clercq E, Balzarini J. Stevens M, et al. Biochem Pharmacol. 2006 Apr 14;71(8):1122-35. doi: 10.1016/j.bcp.2005.12.025. Epub 2006 Jan 24. Biochem Pharmacol. 2006. PMID: 16438940

8

Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives.

Stevens M, Pollicita M, Pannecouque C, Verbeken E, Tabarrini O, Cecchetti V, Aquaro S, Perno CF, Fravolini A, De Clercq E, Schols D, Balzarini J. Stevens M, et al. Antimicrob Agents Chemother. 2007 Apr;51(4):1407-13. doi: 10.1128/AAC.01251-06. Epub 2007 Jan 22. Antimicrob Agents Chemother. 2007. PMID: 17242146 Free PMC article.

9

Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives.

Stevens M, Balzarini J, Lagoja IM, Noppen B, François K, Van Aerschot A, Herdewijn P, De Clercq E, Pannecouque C. Stevens M, et al. Virology. 2007 Aug 15;365(1):220-37. doi: 10.1016/j.virol.2007.03.036. Epub 2007 Apr 24. Virology. 2007. PMID: 17459445 Free article.

10

The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention.

Stevens M, De Clercq E, Balzarini J. Stevens M, et al. Med Res Rev. 2006 Sep;26(5):595-625. doi: 10.1002/med.20081. Med Res Rev. 2006. PMID: 16838299 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,908 results

Search Page